Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PITH domain-containing protein 1 (PITHD1) is a conserved protein found in mammals, characterized by a PITH domain with a jelly roll β-sandwich fold. While structurally similar to the thioredoxin family, PITHD1 lacks the canonical dithiol CXXC motif and does not function as a classic redox enzyme. Functionally, it regulates cellular processes mostly through modulation of transcription and translation, notably activating the internal ribosomal entry site (IRES) to enhance RUNX1 gene expression, thereby promoting megakaryocyte differentiation and normal hematopoiesis. PITHD1 is expressed broadly but is notably upregulated in the olfactory tract in Alzheimer’s disease and downregulated in leukemia, implicating it in neurodegenerative and hematological diseases. In olfactory neuroepithelial cells, PITHD1 alters proliferation rates and triggers pro-inflammatory cytokine secretion, influencing pathways such as JAK-STAT and interleukin signaling. No direct drugs or inhibitors against PITHD1 are reported in the literature, and its therapeutic targeting remains unexplored. It is detected in multiple tissues and body fluids, acts in chromatin organization and signal transduction, and may function as a biomarker for Alzheimer’s disease and cancer progression.
Not applicable; no PITHD1-targeting drugs reported. Mechanistically, enhances RUNX1 expression via activation of IRES and transcriptional upregulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PITH domain-containing protein 1 (PITHD1).